[{"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205530"], "brand_name": ["ACETAZOLAMIDE"], "generic_name": ["ACETAZOLAMIDE"], "manufacturer_name": ["Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."], "product_ndc": ["23155-287", "23155-288"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ACETAZOLAMIDE"], "rxcui": ["197303", "197304"], "spl_id": ["9538a2b5-9fb4-4b51-96e6-e21106d583d7"], "spl_set_id": ["0700a910-79aa-4431-aecf-637fe14fcae8"], "package_ndc": ["23155-287-10", "23155-287-01", "23155-288-01", "23155-288-10"], "is_original_packager": [true], "upc": ["0323155288100", "0323155287103", "0323155287011", "0323155288018"], "nui": ["N0000175517", "N0000000235", "M0020790"], "pharm_class_epc": ["Carbonic Anhydrase Inhibitor [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]"], "pharm_class_cs": ["Sulfonamides [CS]"], "unii": ["O3FX965V0I"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0490-2021", "product_description": "AcetaZOLAMIDE Tablets, USP 125 mg 100 Tablets Rx only NDC 23155-287-01 Manufactured for: Heritage Pharmaceuticals Inc. Eatontown, NJ 07724", "product_quantity": "122 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "M200833"}, {"status": "Terminated", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "88091", "recalling_firm": "AVKARE Inc.", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in Los Angeles California", "recall_number": "D-0631-2021", "product_description": "Phytonadione Tablets 5 mg, Rx Only, 30 Tablets (3x10) Unit Dose, Manufactured for: AvKARE Pulaski, TN 38478. NDC 50268-661-13", "product_quantity": "10 cartons", "reason_for_recall": "Failed Impurities Specification: Out of specification when measuring the impurity degradant D level.", "recall_initiation_date": "20210609", "center_classification_date": "20210616", "termination_date": "20230602", "report_date": "20210623", "code_info": "Lot: 38617 Exp. 10/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0594-2021", "product_description": "Corgard (nadolol tablets, USP) 40 mg 100 Tablets Rx only NDC 27505-101-01 Distributed by US WorldMeds, LLC, Louisville, KY 40241", "product_quantity": "2 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "19T28"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA016620"], "brand_name": ["NITROFURANTOIN MACROCRYSTALS"], "generic_name": ["NITROFURANTOIN MACROCRYSTALS"], "manufacturer_name": ["Alvogen Inc."], "product_ndc": ["47781-306", "47781-307", "47781-308"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NITROFURANTOIN"], "rxcui": ["311994", "311995", "1648759"], "spl_id": ["97785cf3-ab56-4697-3ab6-7451919d889a"], "spl_set_id": ["62c1bb9c-79a2-41e3-9dfa-352f92253881"], "package_ndc": ["47781-306-01", "47781-307-01", "47781-308-01"], "is_original_packager": [true], "upc": ["0347781307011", "0347781306014", "0347781308018"], "nui": ["N0000175494", "M0014892"], "pharm_class_epc": ["Nitrofuran Antibacterial [EPC]"], "pharm_class_cs": ["Nitrofurans [CS]"], "unii": ["927AH8112L"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0421-2021", "product_description": "Nitrofurantoin Macrocrystals Capsules 25 mg 100 Capsules Rx Only NDC 47781-306-01 Manufactured by: Norwich Pharmaceuticals, Inc. Norwich, NY 13815 Distributed by: Alvogen, Inc. Parsippany, NJ 07054 U.S.A.", "product_quantity": "15 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "486942"}, {"status": "Terminated", "city": "Ridgefield", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020850"], "brand_name": ["MICARDIS"], "generic_name": ["TELMISARTAN"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "product_ndc": ["0597-0041", "0597-0039", "0597-0040"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TELMISARTAN"], "rxcui": ["205304", "205305", "213431", "213432", "282755", "284531"], "spl_id": ["333f0ca9-928d-45af-92b9-9ea8a4d02f7d"], "spl_set_id": ["cfb9309f-e0df-4a55-9542-0e869fce05fb"], "package_ndc": ["0597-0039-37", "0597-0040-37", "0597-0041-37"], "is_original_packager": [true], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["U5SYW473RQ"]}, "product_type": "Drugs", "event_id": "87856", "recalling_firm": "Boehringer Ingelheim Pharmaceuticals, Inc.", "address_1": "900 Ridgebury Rd", "address_2": "", "postal_code": "06877-1058", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AR, CO, CT, LA, NC, ND, NH, NJ, OH, PA and PR", "recall_number": "D-0600-2021", "product_description": "Micardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37), Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877", "product_quantity": "15,198 bottles (30 tablets per bottle)", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20210504", "center_classification_date": "20210528", "termination_date": "20211014", "report_date": "20210609", "code_info": "Lot #860412; SEPT 2022", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0501-2021", "product_description": "PHENTERMINE HCL 30MG 100 C4; NDC/UPC 10702002801; RX; CAPSULES", "product_quantity": "16 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "16667A"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203455"], "brand_name": ["NADOLOL"], "generic_name": ["NADOLOL"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-867", "69097-868", "69097-869"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NADOLOL"], "rxcui": ["198006", "198007", "198008"], "spl_id": ["39a5df9f-6bc8-480f-84a6-d051d2cef465"], "spl_set_id": ["c899eedb-4113-45da-acc3-8e181250a7d8"], "package_ndc": ["69097-867-07", "69097-867-15", "69097-867-02", "69097-868-02", "69097-868-07", "69097-868-15", "69097-869-02", "69097-869-07", "69097-869-15"], "is_original_packager": [true], "upc": ["0369097867072", "0369097869076", "0369097868079"], "nui": ["N0000000161", "N0000175556"], "pharm_class_moa": ["Adrenergic beta-Antagonists [MoA]"], "pharm_class_epc": ["beta-Adrenergic Blocker [EPC]"], "unii": ["FEN504330V"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0464-2021", "product_description": "Nadolol Tablets, USP 40 mg 100 Tablets Rx Only NDC 69097-868-07 Manufactured for: Cipla USA Inc. 9100 S. Dadeland Blvd., Suite 1599 Miami, FL 33156", "product_quantity": "40 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "NB100156"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0597-2021", "product_description": "Enalapril Maleate Tablets, USP 2.5 mg 100 tablets Rx only Distributed by: Cardinal Health, NDC 64679-923-02", "product_quantity": "10 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "DV10467"}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87907", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St Bld 950", "address_2": "N/A", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0603-2021", "product_description": "Sodium Chloride 0.9%, USP, 1000 mL, Mfg by: Fresenius Medical Care North America, Waltham, MA 02451, NDC 46163-0300-10", "product_quantity": "48 cases", "reason_for_recall": "Temperature Abuse: Product exposed to temperature outside specified limits.", "recall_initiation_date": "20210428", "center_classification_date": "20210609", "termination_date": "20210917", "report_date": "20210616", "code_info": "Lot #: 20NG02095, Exp. Date October 2021"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077929"], "brand_name": ["MELOXICAM"], "generic_name": ["MELOXICAM"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-158", "69097-159"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MELOXICAM"], "rxcui": ["152695", "311486"], "spl_id": ["2c9a4c52-7394-432a-9e50-b51c8a90972e"], "spl_set_id": ["bb83cd61-0a82-4fe0-b72e-5b715cbd656d"], "package_ndc": ["69097-158-15", "69097-158-07", "69097-158-12", "69097-159-12", "69097-159-07", "69097-159-15"], "is_original_packager": [true], "upc": ["0369097159078", "0369097158071"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["VG2QF83CGL"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0463-2021", "product_description": "Meloxicam Tablets, USP 7.5 mg 100 Tablets Rx Only NDC 69097-158-07 Manufactured for: Cipla USA, Inc. 9100 S. Dadeland Blvd., Suite 1500 Miami, FL 33156", "product_quantity": "576 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "KA03034"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0426-2021", "product_description": "ENOXAPARIN DOFIUM INJRVYION, UPD 150MG/1ML 10X1ML SINGLE DOSE SYRINGES; NDC/UPC 60505-0798-4; RX; SYRINGES", "product_quantity": "64 BOXES", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "CV006"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021591"], "brand_name": ["RIOMET"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["10631-206", "10631-238"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["861025", "861027"], "spl_id": ["8ed86d67-8a49-4334-82c4-1dbf6a489d3b"], "spl_set_id": ["05d4df4b-dfe8-4828-b423-a3d4f2c4114a"], "package_ndc": ["10631-238-01", "10631-238-02", "10631-206-01", "10631-206-02"], "is_original_packager": [true], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "87650", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0334-2021", "product_description": "Riomet (metformin hydrochloride oral solution) 500 mg/5 mL Cherry Flavor, 16 fl. oz., 473 mL bottles Rx Only, Manufactured by: Mikart, LLC, Atlanta, GA 30318, Distributed by: Sun Pharmaceutical Industries Inc., Cranbury, NJ 08512, NDC 10631-206-02.", "product_quantity": "13,834 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Product", "recall_initiation_date": "20210331", "center_classification_date": "20210413", "termination_date": "20220414", "report_date": "20210421", "code_info": "Lot #: J190386A,  X190354A, Exp. 3/2021, J190393A, Exp. 5/2021, A200035A, Exp. 6/2021, B200064A, Exp. 8/2021; H200236A, Exp. 1/2022"}, {"status": "Ongoing", "city": "Elmwood Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87653", "recalling_firm": "Na Na Collection", "address_1": "495 Mola Blvd", "address_2": "Unit #3", "postal_code": "07407-2041", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide with the United States", "recall_number": "D-0354-2021", "product_description": "Triple SupremeZen Gold 3500, Packaged in paper packaging with a pill blister,1 capsule per box, Distributed by VIEW LIFE Distributors Los Angeles CA 90005 UPC 7 15122 05089 4", "product_quantity": "N/A", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.", "recall_initiation_date": "20210330", "center_classification_date": "20210426", "report_date": "20210505", "code_info": "Lot #: GATCO 1805, Exp. Date 12/30/2024  Serial # 715122050894", "more_code_info": ""}, {"status": "Terminated", "city": "Little Ferry", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87609", "recalling_firm": "Namoo Enterprise LLC", "address_1": "215 Gates Rd", "address_2": "Unit S", "postal_code": "07643-1930", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0351-2021", "product_description": "PremierZen Black 5000 capsules, 1 capsule per card/24 capsules per box, Distributed by New Premier Group Los Angeles CA 90006  UPC 7 2817542189 4", "product_quantity": "N/A", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.", "recall_initiation_date": "20210325", "center_classification_date": "20210426", "termination_date": "20210716", "report_date": "20210505", "code_info": "All lots within expiry", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA209803"], "brand_name": ["STEGLATRO"], "generic_name": ["ERTUGLIFLOZIN"], "manufacturer_name": ["Merck Sharp & Dohme LLC"], "product_ndc": ["0006-5363", "0006-5364"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ERTUGLIFLOZIN PIDOLATE"], "rxcui": ["1992810", "1992816", "1992819", "1992821"], "spl_id": ["1616eabd-2ed5-4a98-b255-964e73b63dc8"], "spl_set_id": ["e6f3e718-bb99-48f1-ab94-b9f0af05fed6"], "package_ndc": ["0006-5363-03", "0006-5363-08", "0006-5363-09", "0006-5363-06", "0006-5363-07", "0006-5363-10", "0006-5364-03", "0006-5364-08", "0006-5364-09", "0006-5364-06", "0006-5364-07"], "is_original_packager": [true], "upc": ["0300065363035", "0300065364032"], "unii": ["MLU731K321"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0524-2021", "product_description": "Steglatro (ertugliflozin) tablets 15 mg 30 Tablets Rx only NDC 0006-5364-03 Manuf. for: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, USA", "product_quantity": "215 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "T013566"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M015"], "brand_name": ["DIBUCAINE TOPICAL ANESTHETIC 1% HEMORRHOIDAL"], "generic_name": ["DIBUCAINE"], "manufacturer_name": ["Rugby Laboratories Inc."], "product_ndc": ["0536-1211"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["DIBUCAINE"], "rxcui": ["198601"], "spl_id": ["364c388d-adc9-9763-e063-6294a90a77cd"], "spl_set_id": ["f23c8cd1-98f9-41cd-84d4-cf01c2ede29a"], "package_ndc": ["0536-1211-95"], "is_original_packager": [true], "upc": ["0305361211950"], "nui": ["N0000185508", "N0000175629", "N0000184306", "M0000728"], "pharm_class_epc": ["Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]"], "pharm_class_cs": ["Allergens [CS]"], "unii": ["L6JW2TJG99"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0517-2021", "product_description": "DIBUCAINE TOPICAL ANESTHETIC 1%  HEMORRHOIDAL OINTMENT 28GM ; NDC/UPC 0536-1211-95; OTC; OINTMENT", "product_quantity": "701 CARTON", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA203752"], "brand_name": ["MINIVELLE"], "generic_name": ["ESTRADIOL"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-6610", "68968-6625", "68968-6637", "68968-6650", "68968-6675"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["ESTRADIOL"], "rxcui": ["241946", "242891", "242892", "248478", "1149632", "1356979", "1356997", "1357007", "1357009", "1551622"], "spl_id": ["58e55d14-a9df-4814-9b60-b7c9ce37b0b7"], "spl_set_id": ["6c5c47ab-28ee-11e1-bfc2-0800200c9a66"], "package_ndc": ["68968-6625-8", "68968-6637-8", "68968-6650-8", "68968-6675-8", "68968-6610-8"], "is_original_packager": [true], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E"]}, "product_type": "Drugs", "event_id": "87741", "recalling_firm": "Noven Pharmaceuticals Inc", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0336-2021", "product_description": "Minivelle (estradiol transdermal system) Delivers 0.075 mg/day, 8 patches/box, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186  Dist. by: Noven Therapeutics, LLC Miami, Florida 33186, NDC 68968-6675-8", "product_quantity": "12060 cartons", "reason_for_recall": "Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.", "recall_initiation_date": "20210416", "center_classification_date": "20210420", "termination_date": "20241011", "report_date": "20210428", "code_info": "Lot #: 88584 Exp. 03/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["BLA203314"], "brand_name": ["TRESIBA"], "generic_name": ["INSULIN DEGLUDEC"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-2550", "0169-2660", "0169-2662"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["INSULIN DEGLUDEC"], "rxcui": ["1670011", "1670016", "1670021", "1670023", "2107520", "2107522"], "spl_id": ["e5571110-ca7e-4fcc-88a8-9f1d0104c508"], "spl_set_id": ["456c5e87-3dfd-46fa-8ac0-c6128d4c97c6"], "package_ndc": ["0169-2660-15", "0169-2660-90", "0169-2660-97", "0169-2550-13", "0169-2550-90", "0169-2550-97", "0169-2662-11", "0169-2662-90"], "is_original_packager": [true], "nui": ["M0011417", "N0000175453"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "unii": ["54Q18076QB"]}, "product_type": "Drugs", "event_id": "87537", "recalling_firm": "Novo Nordisk Inc", "address_1": "800 Scudders Mill Rd", "address_2": "N/A", "postal_code": "08536-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0620-2021", "product_description": "TRESIBA (insulin degludec injection) 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. Not for Resale, Rx only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, NDC 0169-2662-90", "product_quantity": "N/A", "reason_for_recall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.", "recall_initiation_date": "20210322", "center_classification_date": "20210610", "termination_date": "20221209", "report_date": "20210421", "code_info": "JZFE233 exp 11/30/2021"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0589-2021", "product_description": "VIMPAT(lacosamide) Tablets ,100 mg, 60-count bottle; Rx Only, Manufactured for: UCB, Inc. Smyrna, GA 30080", "product_quantity": "796 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "912056"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA208411"], "brand_name": ["NARCAN"], "generic_name": ["NALOXONE HYDROCHLORIDE"], "manufacturer_name": ["Emergent Devices Inc."], "product_ndc": ["69547-212", "69547-353"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["NASAL"], "substance_name": ["NALOXONE HYDROCHLORIDE"], "rxcui": ["1725059", "1725064", "1870933", "1870935"], "spl_id": ["1d0be895-cd43-49f3-98d4-72a9c3088616"], "spl_set_id": ["724df050-5332-4d0a-9a5f-17bf08a547e1"], "package_ndc": ["69547-212-04", "69547-212-24", "69547-353-02"], "is_original_packager": [true], "unii": ["F850569PQR"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0473-2021", "product_description": "Narcan (naloxone HCl) Nasal Spray 4 mg Two Pack This box contains two (2) 4-mg doses of naloxone HCl in 0.1 mL of nasal spray. 0.1 mL intranasal spray per unit For use in the nose only Rx only NDC 69547-353-02 Distributed by Adapt Pharma, Inc. Radnor, PA 19087 USA", "product_quantity": "11189 plungers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "201701"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA209482"], "brand_name": ["TRELEGY ELLIPTA"], "generic_name": ["FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE"], "manufacturer_name": ["GlaxoSmithKline LLC"], "product_ndc": ["0173-0887", "0173-0893"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["FLUTICASONE FUROATE", "UMECLIDINIUM BROMIDE", "VILANTEROL TRIFENATATE"], "rxcui": ["1945039", "1945044", "1945047", "1945048", "2395769", "2395771", "2395774", "2395775"], "spl_id": ["676a0120-5f94-4470-b936-2c8cfb32d3fc"], "spl_set_id": ["b5a81d5a-4648-4c7a-951d-33c014a63c7e"], "package_ndc": ["0173-0887-10", "0173-0887-14", "0173-0887-61", "0173-0893-10", "0173-0893-14", "0173-0893-61"], "is_original_packager": [true], "unii": ["40AHO2C6DG", "7AN603V4JV", "JS86977WNV"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0482-2021", "product_description": "Trelegy Ellipta (fluticasone furoate, umeclidinium, and vilanterol inhalation powder) 100 mcg/62.5 mcg/25 mcg; 1 ELLIPTA Inhaler containing 30 doses (60 blisters total) Rx Only NDC 0173-0887-10 GlaxoSmithKline Research Triangle Park, NC 27709", "product_quantity": "903 inhalers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "3X8P"}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA020832"], "brand_name": ["CHLORAPREP ONE-STEP"], "generic_name": ["CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL"], "manufacturer_name": ["CareFusion 213, LLC"], "product_ndc": ["54365-400"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLORHEXIDINE GLUCONATE", "ISOPROPYL ALCOHOL"], "rxcui": ["858726", "998282"], "spl_id": ["42641d19-c870-7770-e063-6294a90acf97"], "spl_set_id": ["8529596f-37e4-c44e-e053-2a91aa0ad014"], "package_ndc": ["54365-400-32"], "is_original_packager": [true], "unii": ["MOR84MUD8E", "ND2M416302"]}, "product_type": "Drugs", "event_id": "87592", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "N/A", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA and to Singapore, Chile, Oman, Columbia, United Arab Emirates, South Africa, Kuwait, Democratic Republic of the Congo, Qatar, Bahrain, Hong Kong, Brazil.", "recall_number": "D-0343-2021", "product_description": "BD ChloraPrep Clear, 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) Sterile Solution, 0.10 fl. oz. (3 ml) each, 25 Applicators in carton, applicator is sterile if package is intact. CareFusion 213, LLC, El Paso, TX 79912, subsidiary of Becton, Dickinson and Co, NDC 54365-400-32 REF 930400", "product_quantity": "952,100 cartons", "reason_for_recall": "Non-sterility.Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, growth of Aspergillus penicillioides, a type of fungus, resulted in a breach of the package integrity.", "recall_initiation_date": "20210319", "center_classification_date": "20210426", "termination_date": "20220929", "report_date": "20210505", "code_info": "Lot and Exp Date:  0065386, 2/28/2023;  0085419, 3/31/2023;  0091666, 3/31/2023;  0149328, 4/30/2023;  0151977, 5/31/2023;  0161217, 5/31/2023;  0175874, 6/30/2023;  0176660, 6/30/2023;  0188805, 6/30/2023;  0211068, 7/31/2023;", "more_code_info": ""}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA206535"], "brand_name": ["ACYCLOVIR"], "generic_name": ["ACYCLOVIR"], "manufacturer_name": ["Zydus Pharmaceuticals (USA) Inc."], "product_ndc": ["68382-048", "68382-049"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ACYCLOVIR SODIUM"], "rxcui": ["1734932", "1734934"], "spl_id": ["515388e8-636f-42f6-a39e-bb4fc7c2e7cb"], "spl_set_id": ["69a98000-adef-4323-89a7-09e035a257d4"], "package_ndc": ["68382-048-01", "68382-048-10", "68382-049-01", "68382-049-10"], "is_original_packager": [true], "unii": ["927L42J563"]}, "product_type": "Drugs", "event_id": "87364", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0315-2021", "product_description": "Acyclovir Sodium Injection 1000mg/20mL (50mg/mL) vial NDC 68382-049-01, For Intravenous Infusion Only MUST BE DILUTED PRIOR TO USE, packaged in 10 x 20mL Single-Dose Vials per pack NDC 68382-049-10, Rx only, Manufactured by: Cadila Healthcare Ltd., Vadodara, India. Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534.", "product_quantity": "816  packs", "reason_for_recall": "Crystallization: customer complaints for crystallization in finished product.", "recall_initiation_date": "20210218", "center_classification_date": "20210330", "termination_date": "20221123", "report_date": "20210407", "code_info": "Lot#: L000155, Exp 12/2021; L000156, Exp 1/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA205874"], "brand_name": ["AURYXIA"], "generic_name": ["FERRIC CITRATE"], "manufacturer_name": ["Akebia Therapeutics, Inc."], "product_ndc": ["59922-631"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TETRAFERRIC TRICITRATE DECAHYDRATE"], "rxcui": ["1594680", "1596023"], "spl_id": ["c7578bda-1b89-4881-95cd-f1201508871f"], "spl_set_id": ["aadd18e0-3752-11e4-8510-0800200c9a66"], "package_ndc": ["59922-631-01"], "is_original_packager": [true], "unii": ["Q91187K011"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0499-2021", "product_description": "Auryxia (ferric citrate) tablets 210 mg* 200 Tablets Rx Only NDC 59922-631-01 Manufactured for and distributed by: Keryx Biopharmaceuticals, Inc. 750 Lexington Avenue, 20th Floor New York, NY 10022 USA", "product_quantity": "136 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "AN0142D"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0537-2021", "product_description": "Benztropine Mesylate Tablets, USP in all pack sizes, styles and strengths Manufactured for: Qualitest Pharmaceuticals Huntsville, AL 35811", "product_quantity": "60 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "S2008031"}, {"status": "Ongoing", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87694", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0356-2021", "product_description": "Flurandrenolide Ointment USP, 0.05%,  Net Wt. 60 grams, Rx Only, Teligent Pharma, Inc. Buena, New Jersey 08310 NDC 52565-017-60", "product_quantity": "3432 tubes", "reason_for_recall": "Failed Impurities/Degradation Specifications:", "recall_initiation_date": "20210409", "center_classification_date": "20210428", "report_date": "20210428", "code_info": "Lot #13974 EXP 7/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021730"], "brand_name": ["LEVALBUTEROL TARTRATE HFA INHALATION"], "generic_name": ["LEVALBUTEROL TARTRATE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-2927"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVALBUTEROL TARTRATE"], "rxcui": ["745791"], "spl_id": ["f9039b6c-2ae3-416b-bc2a-ab6e06e830bf"], "spl_set_id": ["ac85703a-17a2-4f0b-87f4-78f1756d2f85"], "package_ndc": ["0591-2927-54"], "is_original_packager": [true], "unii": ["ADS4I3E22M"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0580-2021", "product_description": "Levalbuterol tartrate HFA Inhalation Aerosol 45 mcg/actuation 200 Metered Inhalations Net Contents: 15 g Rx Only NDC 0591-2927-54 Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA", "product_quantity": "828 inhalers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "200093"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA207932"], "brand_name": ["BELBUCA"], "generic_name": ["BUPRENORPHINE HYDROCHLORIDE"], "manufacturer_name": ["BioDelivery Sciences International Inc"], "product_ndc": ["59385-021", "59385-022", "59385-023", "59385-024", "59385-025", "59385-026", "59385-027"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["BUCCAL"], "substance_name": ["BUPRENORPHINE HYDROCHLORIDE"], "rxcui": ["1716057", "1716063", "1716065", "1716067", "1716069", "1716071", "1716073", "1716075", "1716077", "1716079", "1716081", "1716083", "1716086", "1716090"], "spl_id": ["d8541d8a-992a-4b62-8518-ecd85f480e67"], "spl_set_id": ["bc2b7a3d-72cf-497c-95b0-ba2b71f63c64"], "package_ndc": ["59385-021-01", "59385-021-60", "59385-022-01", "59385-022-60", "59385-023-01", "59385-023-60", "59385-024-01", "59385-024-60", "59385-025-01", "59385-025-60", "59385-026-01", "59385-026-60", "59385-027-01", "59385-027-60"], "is_original_packager": [true], "unii": ["56W8MW3EN1"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0449-2021", "product_description": "Belbuca (buprenorphine hydrochloride) buccal film 600 mcg 60 pouches containing 1 buccal film each Rx only NDC 59385-025-60 Manufactured for: BioDelivery Sciences International, Inc. Raleigh, NC 27612 USA", "product_quantity": "47 cartons", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "BL6002004"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA203813"], "brand_name": ["CANDESARTAN"], "generic_name": ["CANDESARTAN"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-114", "33342-115", "33342-116", "33342-117"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CANDESARTAN CILEXETIL"], "rxcui": ["153822", "153823", "577776", "639537"], "spl_id": ["4079c843-42ee-4f7a-a4a0-9498ba6cf12d"], "spl_set_id": ["8ceb5658-b03c-475d-9ef0-2cd0645191d3"], "package_ndc": ["33342-114-07", "33342-114-51", "33342-114-12", "33342-114-10", "33342-115-07", "33342-115-51", "33342-115-12", "33342-115-10", "33342-116-07", "33342-116-51", "33342-116-12", "33342-116-10", "33342-117-07", "33342-117-51", "33342-117-12", "33342-117-10"], "is_original_packager": [true], "upc": ["0333342117106", "0333342116109", "0333342114105", "0333342114075", "0333342116079", "0333342117076", "0333342115072", "0333342114129", "0333342115102", "0333342117120", "0333342115126", "0333342116123"], "unii": ["R85M2X0D68"]}, "product_type": "Drugs", "event_id": "87607", "recalling_firm": "Macleods Pharma Usa Inc", "address_1": "666 Plainsboro Rd Bldg 200 Ste 230", "address_2": "N/A", "postal_code": "08536-0009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0329-2021", "product_description": "Candesartan Cilexetil Tablets, USP, 4 mg, 30-count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., Daman (U.T.), India, NDC 33342-114-10", "product_quantity": "8015 packs", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20210322", "center_classification_date": "20210412", "termination_date": "20221213", "report_date": "20210421", "code_info": "Lots # : ECD5908C, Exp 7/2021; ECD5909A, ECD5910A,   ECD5911A, ECD5912A, Exp. 09/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA072711"], "brand_name": ["SULINDAC"], "generic_name": ["SULINDAC"], "manufacturer_name": ["Epic Pharma, LLC"], "product_ndc": ["42806-011", "42806-018"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SULINDAC"], "rxcui": ["198238", "198239"], "spl_id": ["fb793a0a-affa-4f9a-a5b4-aa1c84aa475e"], "spl_set_id": ["96c73bd2-4577-487d-a642-bd8f91e94c3a"], "package_ndc": ["42806-018-01", "42806-018-05", "42806-018-10", "42806-011-01", "42806-011-05", "42806-011-10"], "is_original_packager": [true], "upc": ["0342806018057", "0342806011010"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["184SNS8VUH"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0582-2021", "product_description": "Sulindac Tablets, USP, 200mg 100-count bottles, Rx Only, Manufactured by: Epic Pharma, LLC, Laurelton, NY 11413, NDC 42806-011-01", "product_quantity": "92 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "1578F201"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87875", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0378-2021", "product_description": "Haloperidol Decanoate Injection, USP 100 mg/mL, 1 mL Single Dose Vials, Rx Only, Sterile, 10 Vials, Teva Pharmaceuticals, USA, Inc., North Wales, PA  NDC 0703-7131-03", "product_quantity": "7020 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210426", "center_classification_date": "20210514", "termination_date": "20240604", "report_date": "20210526", "code_info": "Lot # 31325394C, exp. date 09/2021 Lot # 31327161B, exp. date 04/2022"}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87592", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "N/A", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA and to Singapore, Chile, Oman, Columbia, United Arab Emirates, South Africa, Kuwait, Democratic Republic of the Congo, Qatar, Bahrain, Hong Kong, Brazil.", "recall_number": "D-0350-2021", "product_description": "ChloraPrep With Tint 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) Non-Sterile Solution - Hi-Lite Orange, 0.10 fl. oz. (3 ml) each, 25 applicators in carton, applicator is sterile if package is intact. CareFusion El Paso, TX 79912, NDC 054365-400-11 Cat. No. 260415", "product_quantity": "7,990,100 cartons", "reason_for_recall": "CGMP Deviations:  Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.", "recall_initiation_date": "20210319", "center_classification_date": "20210426", "termination_date": "20220929", "report_date": "20210505", "code_info": "Lots and Exp dates:  0009104, 12/31/2022;  0013602, 12/31/2022;  0016431, 1/31/2023;  0022273, 1/31/2023;  0023788, 1/31/2023;  0029135, 1/31/2023;  0032694, 1/31/2023;  0038211, 1/31/2023;  0044741, 1/31/2023;  0064598, 2/28/2023;  0104862, 3/31/2023;  0127010, 4/30/2023;  0196060, 6/30/2023;  0224915, 7/31/2023;  8024958, 1/9/2021;  8025595, 1/31/2021;  8025597, 1/31/2021;  8031857, 1/31/2021;  8033645, 1/31/2021;  8038971, 1/28/2021;  8043969, 1/22/2021;  8043978, 1/31/2021;  8046513, 2/1/2021;  8046721, 1/29/2021;  8053669, 2/28/2021;  8053699, 2/28/2021;  8053947, 2/28/2021;  8055949, 2/28/2021;  8059513, 2/28/2021;  8059562, 2/28/2021;  8061970, 2/19/2021;  8064854, 2/28/2021;  8066666, 2/28/2021;  8068686, 2/28/2021;  8069986, 2/28/2021;  8073868, 2/28/2021;  8087798, 3/31/2021;  8099735, 3/31/2021;  8101641, 3/31/2021;  8106743, 4/30/2021;  8107945, 4/30/2021;  8120678, 4/30/2021;  8122947, 4/30/2021;  8131539, 4/30/2021;  8145833, 5/31/2021;  8155989, 5/31/2021;  8172690, 6/30/2021;  8173860, 6/30/2021;  8191600, 6/30/2021;  8221942, 7/31/2021;  8234936, 8/31/2021;  8243851, 8/31/2021;  8247688, 8/31/2021;  8250928, 8/31/2021;  8253987, 8/31/2021;  8256638, 8/31/2021;  8260782, 8/31/2021;  8265685, 9/30/2021;  8274504, 9/30/2021;  8276704, 9/30/2021;  8282698, 9/30/2021;  8284625, 9/30/2021;  8288853, 9/30/2021;  8338776, 11/30/2021;  8339985, 11/30/2021;  8351538, 12/31/2021;  8355672, 12/31/2021;  9007942, 12/31/2021;  9014571, 12/31/2021;  9017726, 1/31/2022;  9021969, 12/31/2021;  9024576, 1/31/2022;  9030949, 1/31/2022;  9078586, 3/31/2022;  9087987, 3/31/2022;  9092771, 3/31/2022;  9128867, 4/30/2022;  9129671, 4/30/2022;  9135822, 5/31/2022;  9143840, 5/31/2022;  9154907, 5/31/2022;  9154939, 5/31/2022;  9158658, 5/31/2022;  9164579, 5/31/2022;  9175663, 6/30/2022;  9176284, 6/30/2022;  9197931, 6/30/2022;  9199822, 6/30/2022;  9200426, 7/31/2022;  9205380, 7/31/2022;  9207927, 7/31/2022;  9213913, 7/31/2022;  9221459, 7/31/2022;  9224855, 7/31/2022;  9231815, 8/31/2022;  9232764, 8/31/2022;  9233646, 8/31/2022;  9235839, 8/31/2022;  9248040, 8/31/2022;  9261980, 9/30/2022;  9270896, 9/30/2022;  9301763, 10/31/2022;  9310176, 10/31/2022;  9317270, 11/30/2022;  9327966, 11/30/2022;  9327969, 11/30/2022;  9339209, 11/30/2022;  9344806, 11/30/2022;  9345964, 10/31/2022;  9351402, 12/31/2022;", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0516-2021", "product_description": "VITAMIN D3 25MCG 180 TABLETS; NDC/UPC 880681168011; OTC; TABLETS", "product_quantity": "19 BOTTLE", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021359"], "brand_name": ["RECTIV"], "generic_name": ["NITROGLYCERIN"], "manufacturer_name": ["Allergan, Inc."], "product_ndc": ["58914-301"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RECTAL"], "substance_name": ["NITROGLYCERIN"], "rxcui": ["1114466", "1114470"], "spl_id": ["f971b230-ba2a-4150-9357-dde0658f2bac"], "spl_set_id": ["603aa9ed-54c4-4a35-ade4-690fa44850e4"], "package_ndc": ["58914-301-80", "58914-301-85"], "is_original_packager": [true], "upc": ["0358914301806"], "nui": ["N0000175415", "M0014874", "N0000009909"], "pharm_class_epc": ["Nitrate Vasodilator [EPC]"], "pharm_class_cs": ["Nitrates [CS]"], "pharm_class_pe": ["Vasodilation [PE]"], "unii": ["G59M7S0WS3"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0419-2021", "product_description": "Rectiv (nitroglycerin) Ointment 0.4% For Intra-anal Use Only 30 g Rx Only NDC 58914-301-80 Mfd. by: Pharbil Waltrop GmbH, Im Wirrigen 25, 45731 Waltrop, Germany Distributed by: Aptalis Pharma US, Inc. Birmingham, AL 35242", "product_quantity": "31 tubes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "2399070"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0498-2021", "product_description": "INVEGA SUSTENNA 156MG/1ML; NDC/UPC 50458056301; RX; SYRINGES", "product_quantity": "534 syringes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "KIB0M00"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201791"], "brand_name": ["LAMOTRIGINE EXTENDED RELEASE"], "generic_name": ["LAMOTRIGINE EXTENDED RELEASE"], "manufacturer_name": ["Endo USA, Inc."], "product_ndc": ["49884-561", "49884-562", "49884-563", "49884-564", "49884-604", "49884-605"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LAMOTRIGINE"], "rxcui": ["850087", "850091", "900156", "900164", "1098608", "1146690"], "spl_id": ["1b224518-6e15-47d1-b1ee-b1e1d92f70ae"], "spl_set_id": ["fb59c76a-9b6f-40ea-ac3a-58c3195c4377"], "package_ndc": ["49884-561-11", "49884-561-01", "49884-561-05", "49884-562-11", "49884-562-01", "49884-562-05", "49884-563-11", "49884-563-01", "49884-563-05", "49884-564-11", "49884-564-01", "49884-564-05", "49884-604-11", "49884-604-01", "49884-604-05", "49884-605-11", "49884-605-01", "49884-605-05"], "is_original_packager": [true], "nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "unii": ["U3H27498KS"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0538-2021", "product_description": "Lamotrigine Extended-Release Tablets 250 mg 30 Tablets Rx Only NDC 49884-604-11 Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Zhejiang 317024 China For Par Pharmaceutical Companes, Inc. Spring Valley, NY 10977 U.S.A.", "product_quantity": "131 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "10116"}, {"country": "United States", "city": "Glendale", "address_1": "610 S Verdugo Rd Apt 31", "reason_for_recall": "Marketed without an approved NDA/ANDA: FDA analysis determined presence of the pharmaceutical ingredients Sibutramine and Fluoxetine", "address_2": "", "product_quantity": "25 pieces (boxes containing 15 sachets)", "code_info": "All Lots", "center_classification_date": "20210611", "distribution_pattern": "Nationwide within the United States", "state": "CA", "product_description": "Imperia Elita Vitaccino Coffee, 10 g sachets, 15 sachets per box, Global Beauty Technologies, Manufactured for: Imperia-Elita Ltd. & Co, KG D- 35435 Wettenberg", "report_date": "20210623", "classification": "Class II", "openfda": {}, "recalling_firm": "DASH XCLUSIVE", "recall_number": "D-0628-2021", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "87923", "more_code_info": "", "recall_initiation_date": "20210511", "postal_code": "91205-2730", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87907", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St Bld 950", "address_2": "N/A", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0606-2021", "product_description": "DELFELX Peritoneal Dialysis Solution with 4.25% Dextrose, Low Magnesium, Low Calcium, 5000 mL, Fresenius Medical Care, Waltham, MA 02451, NDC  49230-0212-50", "product_quantity": "49 cases", "reason_for_recall": "Temperature Abuse: Product exposed to temperature outside specified limits.", "recall_initiation_date": "20210428", "center_classification_date": "20210609", "termination_date": "20210917", "report_date": "20210616", "code_info": "Lot #: 21AK01022, Exp. date July 2022; 20SK01022, Exp. date June 2022"}, {"status": "Completed", "city": "Birmingham", "state": "AL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075388"], "brand_name": ["BUSPIRONE HYDROCHLORIDE"], "generic_name": ["BUSPIRONE HYDROCHLORIDE"], "manufacturer_name": ["Oxford Pharmaceuticals, LLC"], "product_ndc": ["69584-091", "69584-092", "69584-093", "69584-094"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUSPIRONE HYDROCHLORIDE"], "rxcui": ["866018", "866083", "866090", "866094"], "spl_id": ["8c9f66ca-78a9-418c-b11e-ba4391843257"], "spl_set_id": ["97fcebc1-6615-4b9d-b0f3-6434850f407c"], "package_ndc": ["69584-091-10", "69584-091-50", "69584-092-10", "69584-092-50", "69584-093-06", "69584-093-10", "69584-093-50", "69584-094-06", "69584-094-18", "69584-094-50"], "is_original_packager": [true], "upc": ["0369584093502"], "unii": ["207LT9J9OC"]}, "product_type": "Drugs", "event_id": "87873", "recalling_firm": "Oxford Pharmaceuticals, LLC", "address_1": "301 Leaf Lake Pkwy", "address_2": "", "postal_code": "35211-7208", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide.", "recall_number": "D-0602-2021", "product_description": "BusPIRone Hydrochloride Tablets, USP, 15 mg, 100-count bottle, Rx only, Manufactured By: Oxford Pharmaceuticals, LLC Birmingham, Alabama 35211, NDC 69584-093-10", "product_quantity": "6,864 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules", "recall_initiation_date": "20210505", "center_classification_date": "20210602", "report_date": "20210609", "code_info": "Lot #: C21021A, Exp. 03/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["BLA208751"], "brand_name": ["FIASP"], "generic_name": ["INSULIN ASPART INJECTION"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-3201", "0169-3204", "0169-3205", "0169-3206"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["INSULIN ASPART"], "rxcui": ["311040", "1653196", "1653202", "1986354", "1986356", "2205454", "2642808", "2642809"], "spl_id": ["133d5f6e-b40f-47b6-ab47-10dc37114d79"], "spl_set_id": ["834e7efc-393f-4c55-9125-628562a8a5cf"], "package_ndc": ["0169-3201-11", "0169-3201-90", "0169-3204-15", "0169-3204-90", "0169-3204-97", "0169-3205-11", "0169-3205-15", "0169-3205-91", "0169-3205-95", "0169-3206-11", "0169-3206-15", "0169-3206-91", "0169-3206-95"], "is_original_packager": [true], "nui": ["M0011417", "N0000175453"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "unii": ["D933668QVX"]}, "product_type": "Drugs", "event_id": "87537", "recalling_firm": "Novo Nordisk Inc", "address_1": "800 Scudders Mill Rd", "address_2": "N/A", "postal_code": "08536-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0612-2021", "product_description": "Fiasp PenFill (insulin aspart injection) 100 units/mL (U-100), 3 mL cartridge, 5 cartridges per package, Sample Not for Resale, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark,  NDC 0169-3205-91", "product_quantity": "N/A", "reason_for_recall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.", "recall_initiation_date": "20210322", "center_classification_date": "20210610", "termination_date": "20221209", "report_date": "20210421", "code_info": "KS6BF84, Exp 06/30/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA022417"], "brand_name": ["NORVIR"], "generic_name": ["RITONAVIR"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0074-2340", "0074-3333", "0074-1940", "0074-3399"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RITONAVIR"], "rxcui": ["152971", "199249", "900575", "900577", "1926066", "1926069"], "spl_id": ["8ac33865-3c6e-4159-9eaf-5f62bee5b6ca"], "spl_set_id": ["2849298e-de6e-47bb-8194-56e075b33fc3"], "package_ndc": ["0074-3333-30", "0074-1940-63", "0074-3399-30", "0074-2340-30"], "is_original_packager": [true], "upc": ["0300742340304"], "nui": ["N0000000246", "N0000191001", "N0000175889", "N0000190114", "N0000182137", "N0000185607", "N0000190118", "N0000185503", "N0000190113", "N0000182141", "N0000191266", "N0000185507", "N0000187064", "N0000190117"], "pharm_class_moa": ["HIV Protease Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "UDP Glucuronosyltransferases Inducers [MoA]"], "pharm_class_epc": ["Cytochrome P450 3A Inhibitor [EPC]", "Protease Inhibitor [EPC]"], "unii": ["O3J8G9O825"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0404-2021", "product_description": "Norvir Ritonavir Tablets 100 mg 30 Tablets Rx only NDC 0074-3333-30 Abbott Laboratories North Chicago, IL 60064, U.S.A.", "product_quantity": "362 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "1131141"}, {"status": "Terminated", "city": "Manassas", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87627", "recalling_firm": "Antoto-K", "address_1": "7686 Chadds Landing Way", "address_2": "N/A", "postal_code": "20111-1772", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0366-2021", "product_description": "Thumbs Up 7 Red 70K, 10 count blister pack cartons, Distributed by Ummzy LLC., Made in USA, UPC 6 17135 89467 3.", "product_quantity": "200 cartons", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of sildenafil and tadalafil.", "recall_initiation_date": "20210326", "center_classification_date": "20210504", "termination_date": "20220418", "report_date": "20210512", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0555-2021", "product_description": "Chantix (varenicline) Tablets Continuing Month Box Contains: 4 Continuing Weeks (1 mg x 56 tablets) Rx only ; Rx only  Distributed by Pfizer Labs Division of Pfizer, Inc., NY, NY ,10017NDC 0069-0469-56", "product_quantity": "848 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "EM1069"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065261"], "brand_name": ["CEFPROZIL"], "generic_name": ["CEFPROZIL"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-401", "68180-402"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEFPROZIL"], "rxcui": ["309080", "309081"], "spl_id": ["45d1a412-407b-48d4-be64-b9c7ec3c5205"], "spl_set_id": ["3ec55c0a-1456-412e-972f-352b3135c8f2"], "package_ndc": ["68180-401-03", "68180-401-01", "68180-401-02", "68180-402-01", "68180-402-03", "68180-402-02"], "is_original_packager": [true], "upc": ["0368180401032", "0368180402039"], "nui": ["N0000175488", "M0003827"], "pharm_class_epc": ["Cephalosporin Antibacterial [EPC]"], "pharm_class_cs": ["Cephalosporins [CS]"], "unii": ["4W0459ZA4V"]}, "product_type": "Drugs", "event_id": "87602", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0332-2021", "product_description": "Cefprozil for Oral Suspension USP, 250mg/5mL, packaged as a) 50 mL (when mixed) bottles (NDC 68180-402-01); b) 75 mL (when mixed) bottles (NDC 68180-402-02); and c) 100 mL (when mixed) bottles (NDC 68180-402-03); Rx only, Manufactured for: Lupin Pharmaceutical, Inc., Baltimore, MD  21202; Manufactured by: Lupin Limited, Mandideep 462 046, India.", "product_quantity": "a) 6,816 bottles; b) 3,960 bottles and c) 7,038 bottles", "reason_for_recall": "Superpotent Drug", "recall_initiation_date": "20210326", "center_classification_date": "20210412", "termination_date": "20211216", "report_date": "20210421", "code_info": "Lot Numbers: a) F801122, exp. date June 2021; b) F801123, exp. date June 2021; c) F801124, exp. date June 2021"}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA020171"], "brand_name": ["DELFLEX"], "generic_name": ["DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"], "manufacturer_name": ["Fresenius Medical Care North America"], "product_ndc": ["49230-206", "49230-209", "49230-212"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAPERITONEAL"], "substance_name": ["CALCIUM CHLORIDE", "DEXTROSE MONOHYDRATE", "MAGNESIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE"], "spl_id": ["38fb023a-a8db-cd70-e063-6394a90a14f9"], "spl_set_id": ["c29bdfa0-4976-11e2-939b-0002a5d5c51b"], "package_ndc": ["49230-206-92", "49230-206-94", "49230-206-95", "49230-209-92", "49230-209-94", "49230-209-95", "49230-212-92", "49230-212-94", "49230-212-95"], "is_original_packager": [true], "unii": ["LX22YL083G", "451W47IQ8X", "M4I0D6VV5M", "02F3473H9O", "TU7HW0W0QT"]}, "product_type": "Drugs", "event_id": "87907", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St Bld 950", "address_2": "N/A", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0609-2021", "product_description": "DELFLEX Peritoneal Dialysis Solution with 4.25% Dextrose, Low magnesium, Low Calcium and attached stay safe Exchange set, 2000 mL, packs of 5, Rx only, Fresenius Medical Care NA, Waltham, MA 02451, NDC 49230-212-92", "product_quantity": "4 cases", "reason_for_recall": "Temperature Abuse: Product exposed to temperature outside specified limits.", "recall_initiation_date": "20210428", "center_classification_date": "20210609", "termination_date": "20210917", "report_date": "20210616", "code_info": "Lot #: 20PU04030, Exp. date June 2022"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["BLA208583"], "brand_name": ["XULTOPHY 100/3.6"], "generic_name": ["INSULIN DEGLUDEC AND LIRAGLUTIDE"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-2911"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["INSULIN DEGLUDEC", "LIRAGLUTIDE"], "rxcui": ["1860167", "1860172"], "spl_id": ["7ade72ef-d354-430d-afad-3b63b95f5b39"], "spl_set_id": ["21335fe4-d395-4501-ac2a-2f20d7520da9"], "package_ndc": ["0169-2911-15", "0169-2911-90", "0169-2911-97"], "is_original_packager": [true], "nui": ["M0011417", "N0000175453", "N0000178480", "M0160181", "N0000020058"], "pharm_class_cs": ["Insulin [CS]", "Glucagon-Like Peptide 1 [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]", "GLP-1 Receptor Agonist [EPC]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "unii": ["54Q18076QB", "839I73S42A"]}, "product_type": "Drugs", "event_id": "87537", "recalling_firm": "Novo Nordisk Inc", "address_1": "800 Scudders Mill Rd", "address_2": "N/A", "postal_code": "08536-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0623-2021", "product_description": "Xultophy 100/3.6 (insulin degludec and liraglutide injection), 100 units/mL and 3.6 mg/mL, 3 mL Prefilled Pen, SAMPLE, Rx only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, Distributed by: Novo Nordisk Inc, Plainsboro, NJ 08536, NDC 0169-2911-90 (Pen) NDC 0169-2911-97 (Kit)", "product_quantity": "N/A", "reason_for_recall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.", "recall_initiation_date": "20210322", "center_classification_date": "20210610", "termination_date": "20221209", "report_date": "20210421", "code_info": "JP54291, exp 06/20/2021"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0462-2021", "product_description": "Sodium Sulfacetamide 9.8% & Sulfur 4.8% Cleanser (sodium sulfacetamide 9.8% and sulfur 4.8%) Net Wt. 10 oz. (285 g) Rx Only NDC 50096-502-10 Manufactured for: Rosemar Labs, LLC 2100 West Loop South Suite 900 Houston, TX 77027", "product_quantity": "16 tubes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "59314"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["BLA021536"], "brand_name": ["LEVEMIR"], "generic_name": ["INSULIN DETEMIR"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-3687", "0169-6438", "0169-6432"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["INSULIN DETEMIR"], "rxcui": ["484322", "616238", "847239", "847241"], "spl_id": ["580c8514-2277-42bd-9f60-58cf1a6f0b7b"], "spl_set_id": ["d38d65c1-25bf-401d-9c7e-a2c3222da8af"], "package_ndc": ["0169-3687-12", "0169-3687-92", "0169-6438-10", "0169-6438-90", "0169-6438-97", "0169-6438-98", "0169-6432-55", "0169-6432-10"], "is_original_packager": [true], "nui": ["N0000004931", "N0000175453"], "pharm_class_cs": ["Insulin [Chemical/Ingredient]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "unii": ["4FT78T86XV"]}, "product_type": "Drugs", "event_id": "87537", "recalling_firm": "Novo Nordisk Inc", "address_1": "800 Scudders Mill Rd", "address_2": "N/A", "postal_code": "08536-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0614-2021", "product_description": "Levemir FlexTouch (insulin detemir) injection, 100 units/mL (U-100), 3 mL Prefilled Pen, Sample, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, Distributed by: Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-6438-90 (Pen), NDC 0169-6438-98 (Kit)", "product_quantity": "N/A", "reason_for_recall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.", "recall_initiation_date": "20210322", "center_classification_date": "20210610", "termination_date": "20221209", "report_date": "20210421", "code_info": "KP51933 exp 07/31/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA205625"], "brand_name": ["ARNUITY ELLIPTA"], "generic_name": ["FLUTICASONE FUROATE"], "manufacturer_name": ["GlaxoSmithKline LLC"], "product_ndc": ["0173-0874", "0173-0888", "0173-0876"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["FLUTICASONE FUROATE"], "rxcui": ["1547658", "1547660", "1547663", "1547664", "1547666", "1547668", "1547671", "1547672", "2045377", "2045382"], "spl_id": ["99087493-3503-425e-91e3-ba430d16104f"], "spl_set_id": ["50f193ee-1691-486d-9370-a664df63695c"], "package_ndc": ["0173-0888-10", "0173-0874-10", "0173-0874-14", "0173-0876-10", "0173-0876-14"], "is_original_packager": [true], "unii": ["JS86977WNV"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0480-2021", "product_description": "Arnuity Ellipta (fluticasone furoate inhalation powder) 200 mcg 1 Ellipta Inhaler containing 1 Foil Strip of 30 Blisters Rx Only NDC 0173-0876-10 GlaxoSmithKline Research Triangle Park, NC 27709", "product_quantity": "353 inhalers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "5U3D"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209178"], "brand_name": ["IBUPROFEN"], "generic_name": ["IBUPROFEN ORAL"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["59651-032"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IBUPROFEN"], "rxcui": ["197803"], "spl_id": ["82801fa0-32ef-4b77-b03f-fde7331293ae"], "spl_set_id": ["758eeb45-e599-4c1a-969d-8fa33f27bf14"], "package_ndc": ["59651-032-12", "59651-032-47"], "is_original_packager": [true], "upc": ["0359651032121"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0437-2021", "product_description": "IBUPROFEN ORAL SUSPENSION USP 100MG/5ML 120ML ; NDC/UPC 59651-032-12; RX; SUSPENSION (NO DROPS)", "product_quantity": "345 CARTONS", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "BO1020069-A"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0505-2021", "product_description": "SILADRYL 12.5/5ML 118ML SF AF; NDC/UPC 354838135404; OTC; LIQUID", "product_quantity": "78 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Cranford", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077060"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Viona Pharmaceuticals Inc"], "product_ndc": ["72578-035", "72578-036"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["860975", "860981"], "spl_id": ["ca52a4c2-f8fd-4395-a307-3c1ec9c3cf7f"], "spl_set_id": ["85027e6c-d35b-49eb-a234-dd71aa77aee0"], "package_ndc": ["72578-035-01", "72578-035-05", "72578-036-01", "72578-036-05"], "is_original_packager": [true], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "88033", "recalling_firm": "VIONA PHARMACEUTICALS INC", "address_1": "20 Commerce Dr Ste 340", "address_2": "N/A", "postal_code": "07016-3617", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0640-2021", "product_description": "Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 Tablets, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India. Distributed by: Viona Pharmaceuticals Inc. Cranford, NJ 07016  NDC 72578-036-01", "product_quantity": "21240 bottles", "reason_for_recall": "CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.", "recall_initiation_date": "20210601", "center_classification_date": "20210624", "termination_date": "20230531", "report_date": "20210630", "code_info": "Lot M915601 & M915602, Oct 2021"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0487-2021", "product_description": "Hydrocortisone Ointment USP 1% Maximum Strength Net Wt. 1 oz (28 g) NDC 0472-0345-56 Manufactured by: Actavis Mid Atlantic LLC 1877 Kawai Road, Lincolnton, NC 28902", "product_quantity": "23 tubes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021"}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA020171"], "brand_name": ["DELFLEX"], "generic_name": ["DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"], "manufacturer_name": ["Fresenius Medical Care North America"], "product_ndc": ["49230-206", "49230-209", "49230-212"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAPERITONEAL"], "substance_name": ["CALCIUM CHLORIDE", "DEXTROSE MONOHYDRATE", "MAGNESIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE"], "spl_id": ["38fafec0-59d7-1a67-e063-6294a90a8f1e"], "spl_set_id": ["bbc5b820-4973-11e2-a192-0002a5d5c51b"], "package_ndc": ["49230-206-20", "49230-206-30", "49230-206-32", "49230-206-50", "49230-206-60", "49230-206-62", "49230-206-52", "49230-209-23", "49230-209-30", "49230-209-32", "49230-209-50", "49230-209-60", "49230-209-62", "49230-209-52", "49230-212-23", "49230-212-30", "49230-212-32", "49230-212-50", "49230-212-60", "49230-212-62", "49230-212-52", "49230-0209-23"], "is_original_packager": [true], "unii": ["LX22YL083G", "451W47IQ8X", "M4I0D6VV5M", "02F3473H9O", "TU7HW0W0QT"]}, "product_type": "Drugs", "event_id": "87907", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St Bld 950", "address_2": "N/A", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0605-2021", "product_description": "DELFLEX Peritoneal Dialysis Solution with 2.5 % Dextrose, Low Magnesium, Low Calcium, packaged in a) 3000 mL 2 packs (NDC 49230-0209-23), b) 3000 mL (NDC 49230-209-30) and c) 5000 mL (NDC 49230-209-50) Rx only, Fresenius Medical Care NA Waltham, MA 02451", "product_quantity": "672 cases", "reason_for_recall": "Temperature Abuse: Product exposed to temperature outside specified limits.", "recall_initiation_date": "20210428", "center_classification_date": "20210609", "termination_date": "20210917", "report_date": "20210616", "code_info": "Lot #: a) 20PU03043, Exp. Date June 2022; b) 20SU03036, Exp. date July 2022; c) 20Su07012, Exp. date July 2022; 21AU07021, 21AU02037, 21AU01007, 21AU01006, 21AU01019, Exp. date August 2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209255"], "brand_name": ["CYANOCOBALAMIN"], "generic_name": ["CYANOCOBALAMIN"], "manufacturer_name": ["Vitruvias Therapeutics"], "product_ndc": ["69680-112", "69680-113", "69680-121"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["CYANOCOBALAMIN"], "rxcui": ["309594"], "spl_id": ["7c3b0e85-bd17-4998-aaf4-1a873a357ab4"], "spl_set_id": ["2117af8a-723f-4e2f-98a6-83ad2c423751"], "package_ndc": ["69680-112-01", "69680-112-25", "69680-112-10", "69680-113-10", "69680-113-99", "69680-121-05", "69680-121-30", "69680-121-10"], "is_original_packager": [true], "nui": ["M0022794", "N0000175951"], "pharm_class_cs": ["Vitamin B 12 [CS]"], "pharm_class_epc": ["Vitamin B12 [EPC]"], "unii": ["P6YC3EG204"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0595-2021", "product_description": "CYANOCOBAL Injection 1000MCG/ML 25X1ML; NDC/UPC 69680-112-25; RX; MULTI DOSE VIAL", "product_quantity": "6 boxes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "303824"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["BLA208751"], "brand_name": ["FIASP"], "generic_name": ["INSULIN ASPART INJECTION"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-3201", "0169-3204", "0169-3205", "0169-3206"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["INSULIN ASPART"], "rxcui": ["311040", "1653196", "1653202", "1986354", "1986356", "2205454", "2642808", "2642809"], "spl_id": ["133d5f6e-b40f-47b6-ab47-10dc37114d79"], "spl_set_id": ["834e7efc-393f-4c55-9125-628562a8a5cf"], "package_ndc": ["0169-3201-11", "0169-3201-90", "0169-3204-15", "0169-3204-90", "0169-3204-97", "0169-3205-11", "0169-3205-15", "0169-3205-91", "0169-3205-95", "0169-3206-11", "0169-3206-15", "0169-3206-91", "0169-3206-95"], "is_original_packager": [true], "nui": ["M0011417", "N0000175453"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "unii": ["D933668QVX"]}, "product_type": "Drugs", "event_id": "87537", "recalling_firm": "Novo Nordisk Inc", "address_1": "800 Scudders Mill Rd", "address_2": "N/A", "postal_code": "08536-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0613-2021", "product_description": "Fiasp (insulin aspart injection), 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. Not for Resale, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, NDC 0169-3201-90", "product_quantity": "N/A", "reason_for_recall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.", "recall_initiation_date": "20210322", "center_classification_date": "20210610", "termination_date": "20221209", "report_date": "20210421", "code_info": "KS6BX63 exp 10/31/2022;   KS6AK76 exp  05/31/2022;   KS6BR92 exp 09/30/2022"}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87710", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "N/A", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0335-2021", "product_description": "Betadine (Povidone-Iodine) 5%, 0.5mL per syringe Single Use Syringe Rx only, For Topical Ophthalmic Use (DO NOT INJECT) STERILE OPHTHALMIC SOLUTION, PRESERVATIVE FREE, Edge Pharma, LLC 856 Hercules Dr. Colchester, VT 05446 Customer Service (USA) 1-802-992-1178", "product_quantity": "5850 syringes", "reason_for_recall": "Defective container; syringe content migrating past the seal of the plunger may cause a lack of assurance of sterility", "recall_initiation_date": "20210412", "center_classification_date": "20210419", "termination_date": "20220211", "report_date": "20210428", "code_info": "Lot 02-2021-16@4 BUD 5/31/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021924"], "brand_name": ["TIROSINT"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["IBSA Pharma Inc."], "product_ndc": ["71858-0005", "71858-0013", "71858-0012", "71858-0010", "71858-0015", "71858-0020", "71858-0025", "71858-0030", "71858-0035", "71858-0040", "71858-0045", "71858-0050", "71858-0055", "71858-0060", "71858-0017"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["905451", "905453", "905455", "905457", "905458", "905460", "905462", "905464", "966404", "966405", "966406", "966407", "966412", "966413", "966415", "966417", "966420", "966423", "966426", "966434", "1923047", "1923049", "1923050", "1923052", "2630738", "2630740", "2630742", "2630744", "2630746", "2630748"], "spl_id": ["2c23e4a0-0b55-30e6-e063-6294a90af05b"], "spl_set_id": ["7a7ade79-0165-4e31-b84e-667416c00c7e"], "package_ndc": ["71858-0013-4", "71858-0013-1", "71858-0013-2", "71858-0012-4", "71858-0012-1", "71858-0012-2", "71858-0005-4", "71858-0005-1", "71858-0005-2", "71858-0010-4", "71858-0010-1", "71858-0010-2", "71858-0015-4", "71858-0015-1", "71858-0015-2", "71858-0020-4", "71858-0020-1", "71858-0020-2", "71858-0025-4", "71858-0025-1", "71858-0025-2", "71858-0030-4", "71858-0030-1", "71858-0030-2", "71858-0035-4", "71858-0035-1", "71858-0035-2", "71858-0040-4", "71858-0040-1", "71858-0040-2", "71858-0045-4", "71858-0045-1", "71858-0045-2", "71858-0050-4", "71858-0050-1", "71858-0050-2", "71858-0055-4", "71858-0055-1", "71858-0055-2", "71858-0060-4", "71858-0060-1", "71858-0060-2", "71858-0017-4", "71858-0017-1", "71858-0017-2"], "is_original_packager": [true], "upc": ["0371858001540", "0371858006040", "0371858003049", "0371858004541", "0371858001045", "0371858004046", "0371858001243", "0371858001748", "0371858002042", "0371858003544", "0371858001342", "0371858005043"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0495-2021", "product_description": "TIROSINT(levothyroxine sodium) capsules  175MCG  3 blisters X10 capsules; NDC/UPC 71858-0055-4; RX; CAPSULES", "product_quantity": "25 boxes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "200606"}, {"status": "Ongoing", "city": "Ridgewood", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87711", "recalling_firm": "Hyobin LLC", "address_1": "455 S Pleasant Ave", "address_2": "N/A", "postal_code": "07450-5413", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0381-2021", "product_description": "PremierZen Extreme 3000, packaged in   cardboard blisters containing one capsule per card, Distributed by Yolo Studio,  Cliffside Park, NJ", "product_quantity": "500 cards", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil.", "recall_initiation_date": "20210406", "center_classification_date": "20210514", "report_date": "20210526", "code_info": "all lots"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M006"], "brand_name": ["BENZOYL PEROXIDE"], "generic_name": ["BENZOYL PEROXIDE"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "product_ndc": ["45802-101"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["BENZOYL PEROXIDE"], "rxcui": ["308689"], "spl_id": ["eae4cff7-3c1c-429e-85ec-ba5f2075562b"], "spl_set_id": ["0ba5e88c-a4d5-4550-93fa-d3d7fee45f9f"], "package_ndc": ["45802-101-96"], "is_original_packager": [true], "unii": ["W9WZN9A0GM"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0542-2021", "product_description": "Benzoyl Peroxide 2.5% Aqueous Base, Acne Treatment Gel Net Wt. 2.1 oz (60 g) NDC 45802-101-96 Distributed By Perrigo Allegan, MI 49010", "product_quantity": "5 tubes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Memphis", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "88008", "recalling_firm": "McKesson Corporation dba McKesson Drug Company", "address_1": "4853 Crumpler Rd", "address_2": "N/A", "postal_code": "38141-8301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0630-2021", "product_description": "Levetiracetam Tablets USP, 250 mg UD 100 Tablets (10x10) boxes, Rx Only, Distributed By: McKesson Corporation 4971 Southridge Blvd., Suite 101 Memphis, TN 38141  Manufactured by: Aurobindo Pharma Limited Hyderabad-500 090, India  NDC 63739-795-10", "product_quantity": "210 cartons", "reason_for_recall": "Labeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as Naproxen Tablets 500 mg. Product is labeled correctly as Levetiracetam", "recall_initiation_date": "20210526", "center_classification_date": "20210615", "termination_date": "20220929", "report_date": "20210616", "code_info": "Lot: 0000124916 Exp. 09/30/2022"}, {"status": "Terminated", "city": "Tajpura", "state": "N/A", "country": "India", "classification": "Class I", "openfda": {"application_number": ["ANDA202130"], "brand_name": ["TELMISARTAN"], "generic_name": ["TELMISARTAN"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "product_ndc": ["62332-087", "62332-088", "62332-089"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TELMISARTAN"], "rxcui": ["205304", "205305", "282755"], "spl_id": ["eee590f3-5296-4091-a146-e4feedf76565"], "spl_set_id": ["c62d424c-7630-413c-be2c-3932831c3f1d"], "package_ndc": ["62332-087-10", "62332-087-30", "62332-087-91", "62332-088-10", "62332-088-30", "62332-088-91", "62332-089-10", "62332-089-30", "62332-089-91", "1905005661"], "is_original_packager": [true], "upc": ["0362332087303", "0362332088300", "0362332089307"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["U5SYW473RQ"]}, "product_type": "Drugs", "event_id": "87533", "recalling_firm": "Alembic Pharmaceuticals Limited", "address_1": "Near Baska", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0326-2021", "product_description": "Telmisartan Tablets, USP 20 mg, 30-count bottles, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division) Panelav 38935, Gujarat, India Manufactured for: Alembic Pharmaceuticals, Inc. 750 Route 202, Bridgewater, NJ 08807, NDC 62332-087-30", "product_quantity": "12288 bottles", "reason_for_recall": "Labeling: Label-mixup", "recall_initiation_date": "20210317", "center_classification_date": "20210407", "termination_date": "20221205", "report_date": "20210414", "code_info": "Lot #: 1905005661, Exp March 2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0530-2021", "product_description": "NAT B VIT D3 2000U 100; NDC/UPC 079854041125; OTC; TABLETS", "product_quantity": "47 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["BLA208751"], "brand_name": ["FIASP"], "generic_name": ["INSULIN ASPART INJECTION"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-3201", "0169-3204", "0169-3205", "0169-3206"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["INSULIN ASPART"], "rxcui": ["311040", "1653196", "1653202", "1986354", "1986356", "2205454", "2642808", "2642809"], "spl_id": ["133d5f6e-b40f-47b6-ab47-10dc37114d79"], "spl_set_id": ["834e7efc-393f-4c55-9125-628562a8a5cf"], "package_ndc": ["0169-3201-11", "0169-3201-90", "0169-3204-15", "0169-3204-90", "0169-3204-97", "0169-3205-11", "0169-3205-15", "0169-3205-91", "0169-3205-95", "0169-3206-11", "0169-3206-15", "0169-3206-91", "0169-3206-95"], "is_original_packager": [true], "nui": ["M0011417", "N0000175453"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "unii": ["D933668QVX"]}, "product_type": "Drugs", "event_id": "87537", "recalling_firm": "Novo Nordisk Inc", "address_1": "800 Scudders Mill Rd", "address_2": "N/A", "postal_code": "08536-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0611-2021", "product_description": "Fiasp FlexTouch (insulin aspart injection) 100 units/mL (U-100), 3 mL Prefilled Pen, Sample. Not for Resale, Rx only, Manufactured by: Novo Nordisk, Inc., Bagsvaerd, Denmark, Distributed by: Novo Nordisk Inc, Plainsboro, NJ 08536, NDC 0169-3204-90 (Pen), NDC 0169-3204-97 (Kit)", "product_quantity": "N/A", "reason_for_recall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.", "recall_initiation_date": "20210322", "center_classification_date": "20210610", "termination_date": "20221209", "report_date": "20210421", "code_info": "KP51207 exp 06/30/2022;   KP52618 exp 10/31/2022"}, {"status": "Terminated", "city": "Sanford", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019452"], "brand_name": ["DERMOTIC"], "generic_name": ["FLUOCINOLONE ACETONIDE"], "manufacturer_name": ["Royal Pharmaceuticals"], "product_ndc": ["68791-103"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["AURICULAR (OTIC)"], "substance_name": ["FLUOCINOLONE ACETONIDE"], "rxcui": ["1191299", "1191301"], "spl_id": ["195c48d9-bb7a-4c89-b6b8-35fff5aefff8"], "spl_set_id": ["eb00f222-8105-4e05-90e8-bbd129784364"], "package_ndc": ["68791-103-20"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["0CD5FD6S2M"]}, "product_type": "Drugs", "event_id": "87990", "recalling_firm": "Hill Dermaceuticals, Inc.", "address_1": "2650 S Mellonville Ave", "address_2": "N/A", "postal_code": "32773-9311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0637-2021", "product_description": "DermOtic Oil (fluocinolone acetonide oil) 0.01% Ear Drops  20 mL bottles, Rx only,  Manufactured by: Hill Dermaceuticals, Inc. Sanford, FL 32773 for: Royal Pharmaceuticals Manasquan, NJ 08736, NDC 68791-103-20", "product_quantity": "34,561 bottles for sale; 773 bottles for samples", "reason_for_recall": "Presence of Foreign Substance: Potential for broken glass within the glass pipette of the dropper.", "recall_initiation_date": "20210521", "center_classification_date": "20210623", "termination_date": "20220928", "report_date": "20210630", "code_info": "Lot #: 19K036D, 19L039E Exp. 05/21; 20A001E, 20A003D, 20A003E, Exp. 07/21; 20C013G Exp. 09/21; 20E025F, 20E025G, 20E025H Exp. 12/21; 20H041D, 20H041F Exp. 02/22; 20J043E Exp. 03/22; 20K050F Exp. 04/22; 20L055E Exp. 06/22; 21C015E, 21C018E Exp. 09/22"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0416-2021", "product_description": "RESTASIS 0.05%30X 0.4ML OPTH PF; NDC/UPC 23916330; RX; DROPS/Restasis 0.05% 60x0.4 mL OPTH PF; NDC/UPC 23916330; RX", "product_quantity": "3688 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "T1202"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076805"], "brand_name": ["CHILDRENS LORATADINE"], "generic_name": ["LORATADINE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["51672-2131"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["LORATADINE"], "rxcui": ["692783"], "spl_id": ["38f72eeb-30a5-812a-e063-6294a90a6890"], "spl_set_id": ["58eaab62-ac36-4080-8ded-9b472dddc617"], "package_ndc": ["51672-2131-4", "51672-2131-8", "51672-2131-1"], "is_original_packager": [true], "unii": ["7AJO3BO7QN"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0572-2021", "product_description": "Children's Loratadine Oral Solution USP, 5 mg/5 mL (Antihistamine) Allergy Grape Flavor 4 FL OZ (120 mL) NDC 51672-2131-8 Distributed by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532", "product_quantity": "2907 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021911"], "brand_name": ["BANZEL"], "generic_name": ["RUFINAMIDE"], "manufacturer_name": ["Eisai Inc."], "product_ndc": ["62856-582", "62856-583", "62856-584"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RUFINAMIDE"], "rxcui": ["824295", "824299", "824301", "824303", "1092357", "1092360"], "spl_id": ["0cc6f13a-0289-45f7-980e-3196d7489d75"], "spl_set_id": ["0a3fa925-1abd-458a-bd57-4ae780a1ef2d"], "package_ndc": ["62856-582-52", "62856-582-04", "62856-583-14", "62856-583-52", "62856-584-46"], "is_original_packager": [true], "upc": ["0362856584463", "0362856582520"], "unii": ["WFW942PR79"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0472-2021", "product_description": "Banzel (rufinamide) tablets 200 mg 120 tablets Rx only NDC 62856-582-52 Manufactured by Eisai Co., Ltd. Marketed by Eisai Inc. Woodcliff Lake, NJ 07677", "product_quantity": "30 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "80643"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0502-2021", "product_description": "PHENTERMINE HCL 37.5MG 100 C4; NDC/UPC 10702002901; RX; CAPSULES", "product_quantity": "237 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "16649A"}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA206535"], "brand_name": ["ACYCLOVIR"], "generic_name": ["ACYCLOVIR"], "manufacturer_name": ["Zydus Pharmaceuticals (USA) Inc."], "product_ndc": ["68382-048", "68382-049"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ACYCLOVIR SODIUM"], "rxcui": ["1734932", "1734934"], "spl_id": ["515388e8-636f-42f6-a39e-bb4fc7c2e7cb"], "spl_set_id": ["69a98000-adef-4323-89a7-09e035a257d4"], "package_ndc": ["68382-048-01", "68382-048-10", "68382-049-01", "68382-049-10"], "is_original_packager": [true], "unii": ["927L42J563"]}, "product_type": "Drugs", "event_id": "87364", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0316-2021", "product_description": "Acyclovir Sodium Injection 500mg/10mL (50mg/mL) vial NDC 68382-048-01, For Intravenous Infusion Only MUST BE DILUTED PRIOR TO USE, packaged in 10 x 10mL Single-Dose Vials per pack NDC 68382-048-10, Rx only, Manufactured by: Cadila Healthcare Ltd., Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534.", "product_quantity": "1,638 packs", "reason_for_recall": "Crystallization: customer complaints for crystallization in finished product.", "recall_initiation_date": "20210218", "center_classification_date": "20210330", "termination_date": "20221123", "report_date": "20210407", "code_info": "Lot#: L000126, L000127, Exp 12/31/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090685"], "brand_name": ["POLYETHYLENE GLYCOL 3350"], "generic_name": ["POLYETHYLENE GLYCOL 3350"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "product_ndc": ["45802-868"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["POLYETHYLENE GLYCOL 3350"], "rxcui": ["876193"], "spl_id": ["1a88ad2b-b557-4991-aff2-a1f96159bbdc"], "spl_set_id": ["e138b8c8-48de-48cd-8baa-2cc148cef62c"], "package_ndc": ["45802-868-01", "45802-868-03", "45802-868-02", "45802-868-66"], "is_original_packager": [true], "nui": ["N0000010288", "N0000175811", "N0000009871"], "pharm_class_moa": ["Osmotic Activity [MoA]"], "pharm_class_epc": ["Osmotic Laxative [EPC]"], "pharm_class_pe": ["Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "unii": ["G2M7P15E5P"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0544-2021", "product_description": "Polyethylene Glycol 3350 Powder for Solution, Laxative Net Wt 4.1 oz (119 g) 7 Once-Daily Doses NDC 45802-868-01 Distributed by Perrigo Allegan, MI 49010", "product_quantity": "163 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0531-2021", "product_description": "Vitamin D3 Cholecalciferol 50,000 IU Dietary Supplement 100 Capsules NDC 75834-020-01 Marketed by: Nivagen Pharmaceuticals, Inc. Sacramento, CA 95827", "product_quantity": "523 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA070583"], "brand_name": ["BUPIVACAINE HYDROCHLORIDE"], "generic_name": ["BUPIVACAINE HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-1159", "0409-1160", "0409-1162", "0409-1163", "0409-1165", "0409-9043", "0409-9046", "0409-9045", "0409-9042"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["EPIDURAL", "INFILTRATION", "INTRACAUDAL", "PERINEURAL"], "substance_name": ["BUPIVACAINE HYDROCHLORIDE"], "rxcui": ["1012377", "1012384", "1012396", "1012404", "1672917", "1672919", "1724786", "1724787", "1724880", "1724884", "1725078", "1725082", "1867594", "1867596"], "spl_id": ["3c6a5b9f-4ea0-4ccd-a384-a90e4ad379e7"], "spl_set_id": ["02a845c3-4521-4926-e397-25ab536e7cf6"], "package_ndc": ["0409-1159-18", "0409-1159-01", "0409-1159-19", "0409-1159-02", "0409-1160-18", "0409-1160-01", "0409-1162-18", "0409-1162-01", "0409-1162-19", "0409-1162-02", "0409-1163-18", "0409-1163-01", "0409-1165-18", "0409-1165-01", "0409-1165-19", "0409-1165-02", "0409-9043-11", "0409-9043-01", "0409-9046-11", "0409-9046-01", "0409-9045-11", "0409-9045-01", "0409-9045-16", "0409-9045-17", "0409-9042-11", "0409-9042-01", "0409-9042-16", "0409-9042-17"], "is_original_packager": [true], "unii": ["7TQO7W3VT8", "30Q7KI53AK"]}, "product_type": "Drugs", "event_id": "87837", "recalling_firm": "PFIZER, INC", "address_1": "275 N Field Dr Bldg H3-3N", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Puerto Rico, and Guam", "recall_number": "D-0626-2021", "product_description": "0.5% Bupivacaine Hydrochloride Injection, USP, 150 mg/30 mL (5 mg/mL), 30 mL Single-dose Teartop Vials (NDC 0409-1162-19), packaged in 25 vials per tray (NDC 0409-1162-02), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA.", "product_quantity": "163,957 vials", "reason_for_recall": "Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contain 1% Lidocaine HCl Injection, USP and some vials labeled to contain 1% Lidocaine HCl Injection, USP may contain 0.5% Bupivacaine Hydrochloride Injection, USP", "recall_initiation_date": "20210503", "center_classification_date": "20210610", "termination_date": "20230404", "report_date": "20210609", "code_info": "Lot EG6023, Exp. 07/01/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87266", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0338-2021", "product_description": "Betamethasone Dipropionate Ointment USP, 0.05% (Augmented), packaged in  15 grams tubes, Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 08310, NDC 52565-019-15", "product_quantity": "104,784 tubes", "reason_for_recall": "Failed Impurities/ Degradation Specifications -  OOS for know impurity Betamethasone 17- propionate.", "recall_initiation_date": "20210202", "center_classification_date": "20210423", "termination_date": "20240815", "report_date": "20210505", "code_info": "Lot #: 14297, Exp 9/2021; 15372, Exp 3/2022; 15841, Exp 8/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0408-2021", "product_description": "OFLOXACIN 0.3% 5ML OPTH; NDC/UPC 17478071310; RX; DROPS", "product_quantity": "339 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "427297"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA207964"], "brand_name": ["READYPREP CHG"], "generic_name": ["CHLORHEXIDINE GLUCONATE 2%"], "manufacturer_name": ["Medline Industries, LP"], "product_ndc": ["53329-244"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLORHEXIDINE GLUCONATE"], "rxcui": ["846127"], "spl_id": ["21b70574-3cd6-865f-e063-6394a90a54ba"], "spl_set_id": ["458cf999-5e3d-4d4d-82d5-02118c331893"], "package_ndc": ["53329-244-01", "53329-244-03"], "is_original_packager": [true], "unii": ["MOR84MUD8E"]}, "product_type": "Drugs", "event_id": "88005", "recalling_firm": "Medline Industries Inc", "address_1": "3 Lakes Dr", "address_2": "N/A", "postal_code": "60093-2753", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA and Isreal", "recall_number": "D-0624-2021", "product_description": "READYPREP CHG, 2% Chlorhexidine Gluconate Cloth, 2 9x10.5 in (22.9x26.7 cm) Disposable Cloths, Non-Sterile, Single Use Only, Manufactured by Medline Industries, Inc., Northfield, IL 60093 USA.  NDC: 53329-244-01", "product_quantity": "231,936 packs", "reason_for_recall": "Superpotent Drug: Product is above specification for active ingredient, 2% Chlorhexidine Gluconate.", "recall_initiation_date": "20210514", "center_classification_date": "20210610", "termination_date": "20240807", "report_date": "20210616", "code_info": "Lot #:: 19EEA027, Exp May 2021; 19GEA049, Exp August 2021; 19HEA044, Exp Sept 2021"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA022352"], "brand_name": ["COLCRYS"], "generic_name": ["COLCHICINE"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "product_ndc": ["64764-119"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["COLCHICINE"], "rxcui": ["197541", "858071"], "spl_id": ["6f7b50e5-99b4-45e8-90d4-6aa8fc54a5a4"], "spl_set_id": ["56c130d1-7581-4152-99a2-0014ee9366c0"], "package_ndc": ["64764-119-07", "64764-119-06", "64764-119-01", "64764-119-03", "64764-119-05", "64764-119-10"], "is_original_packager": [true], "upc": ["0364764119072"], "nui": ["N0000193949", "M0000713"], "pharm_class_epc": ["Alkaloid [EPC]"], "pharm_class_cs": ["Alkaloids [CS]"], "unii": ["SML2Y3J35T"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0571-2021", "product_description": "Colcrys (colchicine, USP) tablets 0.6 mg 30 tablets Rx only Distributed by: Takeda Pharmaceuticals America, Inc. Deerfield, IL 60015,NDC 64764-119-07", "product_quantity": "160 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "11888415"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0532-2021", "product_description": "Vitamin D3 Cholecalciferol 50,000 IU Dietary Supplement 12 Capsules NDC 75834-020-12 Marketed by: Nivagen Pharmaceuticals, Inc. Sacramento, CA 95827 USA", "product_quantity": "205 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0441-2021", "product_description": "ESZOPICLONE 3MG 100 C4; NDC/UPC 65862096901; RX; TABLETS", "product_quantity": "29 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "GS0320010-A"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203536"], "brand_name": ["VALSARTAN"], "generic_name": ["VALSARTAN"], "manufacturer_name": ["Jubilant Cadista Pharmacuticals Inc."], "product_ndc": ["59746-360", "59746-361", "59746-362", "59746-363"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALSARTAN"], "rxcui": ["349199", "349200", "349201", "349483"], "spl_id": ["9c828bee-09d3-4021-99e7-e5fd3e83741c"], "spl_set_id": ["9402b022-5809-4251-dfef-54f6ef5723fe"], "package_ndc": ["59746-360-30", "59746-360-90", "59746-360-05", "59746-360-03", "59746-361-30", "59746-361-90", "59746-361-05", "59746-361-03", "59746-362-30", "59746-362-90", "59746-362-05", "59746-362-03", "59746-363-30", "59746-363-90", "59746-363-67", "59746-363-32"], "is_original_packager": [true], "upc": ["0359746363321", "0359746363307", "0359746361037", "0359746362034", "0359746360306", "0359746360030", "0359746361303", "0359746362300"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0461-2021", "product_description": "Valsartan Tablets USP 40 mg 30 Scored Tablets Rx Only NDC 59746-360-30 Manufactured by: Jubilant Generics Ltd. Roorkee-247661, India", "product_quantity": "20 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "VR120022A"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA101995"], "brand_name": ["COLLAGENASE SANTYL"], "generic_name": ["COLLAGENASE SANTYL"], "manufacturer_name": ["SMITH & NEPHEW, INC"], "product_ndc": ["50484-010"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["COLLAGENASE CLOSTRIDIUM HISTOLYTICUM"], "rxcui": ["309509"], "spl_id": ["155959d1-0367-4fb6-8877-29099d08801c"], "spl_set_id": ["6b6fbfc6-98fa-46aa-88ef-ab00fbb08ffd"], "package_ndc": ["50484-010-30", "50484-010-90"], "is_original_packager": [true], "upc": ["0350484010300"], "unii": ["9X7O8V25IT"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0567-2021", "product_description": "Collagenase Santyl Ointment 250 units/g 30 grams Rx Only Marketed by Smith & Nephew, Inc., Fort Worth, TX 76107, NDC 50484-010-30", "product_quantity": "1391 tubes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "191960"}, {"status": "Ongoing", "city": "Elmwood Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87751", "recalling_firm": "QMart", "address_1": "495 Mola Blvd", "address_2": "N/A", "postal_code": "07407-2041", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0369-2021", "product_description": "PremierZen Extreme 3000, Male Sexual Performance Enhancement, 1 Capsule, UPC 728175421887", "product_quantity": "500 boxes", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.", "recall_initiation_date": "20210331", "center_classification_date": "20210506", "report_date": "20210512", "code_info": "All"}, {"status": "Terminated", "city": "Bensalem", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA206107"], "brand_name": ["ASENAPINE"], "generic_name": ["ASENAPINE"], "manufacturer_name": ["Sigmapharm Laboratories, LLC"], "product_ndc": ["42794-016", "42794-017"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBLINGUAL"], "substance_name": ["ASENAPINE"], "rxcui": ["859975", "859981"], "spl_id": ["f1f1f3b2-6b49-a523-e053-2995a90ad0c9"], "spl_set_id": ["3512687b-d1c7-45c4-8822-3a2ad53575a5"], "package_ndc": ["42794-016-22", "42794-016-08", "42794-016-10", "42794-017-22", "42794-017-08", "42794-017-10"], "is_original_packager": [true], "upc": ["0342794016226", "0342794017100", "0342794016080", "0342794016103", "0342794017087", "0342794017223"], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["JKZ19V908O"]}, "product_type": "Drugs", "event_id": "87748", "recalling_firm": "SigmaPharm Laboratories LLC", "address_1": "3375 Progress Dr", "address_2": "N/A", "postal_code": "19020-5801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0380-2021", "product_description": "Asenapine Sublingual Tablets, 10 mg, Rx only, 60 Tablets, Sigmapharm Laboratories, LLC, Bensalem, PA, 19020,   NDC 42794-017-10", "product_quantity": "8786 bottles", "reason_for_recall": "Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent", "recall_initiation_date": "20210419", "center_classification_date": "20210514", "termination_date": "20220926", "report_date": "20210526", "code_info": "Lots # 2012801, 2012901, 2013001 & Lot 2100501, Exp AUG 2022; 2100101, Exp NOV 2022"}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA020171"], "brand_name": ["DELFLEX"], "generic_name": ["DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"], "manufacturer_name": ["Fresenius Medical Care North America"], "product_ndc": ["49230-206", "49230-209", "49230-212"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAPERITONEAL"], "substance_name": ["CALCIUM CHLORIDE", "DEXTROSE MONOHYDRATE", "MAGNESIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE"], "spl_id": ["38fb023a-a8db-cd70-e063-6394a90a14f9"], "spl_set_id": ["c29bdfa0-4976-11e2-939b-0002a5d5c51b"], "package_ndc": ["49230-206-92", "49230-206-94", "49230-206-95", "49230-209-92", "49230-209-94", "49230-209-95", "49230-212-92", "49230-212-94", "49230-212-95"], "is_original_packager": [true], "unii": ["LX22YL083G", "451W47IQ8X", "M4I0D6VV5M", "02F3473H9O", "TU7HW0W0QT"]}, "product_type": "Drugs", "event_id": "87907", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St Bld 950", "address_2": "N/A", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0608-2021", "product_description": "DELFLEX Peritoneal Dialysis Solution with 2.5% Dextrose, Low magnesium, Low Calcium and attached stay safe Exchange set, packaged in a) 2500 mL  (NDC 49230-209-94) and b) 2000mL, packs of 5 (NDC 49230-209-92) Fresenius Medical Care NA, Waltham, MA 02451,", "product_quantity": "39 cases", "reason_for_recall": "Temperature Abuse: Product exposed to temperature outside specified limits.", "recall_initiation_date": "20210428", "center_classification_date": "20210609", "termination_date": "20210917", "report_date": "20210616", "code_info": "Lot #: a) 20PU02010, Exp. date June 2022 and b) 20SU04033, Exp. date July 2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M006"], "brand_name": ["BENZOYL PEROXIDE"], "generic_name": ["BENZOYL PEROXIDE"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "product_ndc": ["45802-318"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["BENZOYL PEROXIDE"], "rxcui": ["142034"], "spl_id": ["96b6043b-6127-4632-b248-f466711f158e"], "spl_set_id": ["8730957f-f051-4aa5-b5ab-3186051b3789"], "package_ndc": ["45802-318-01", "45802-318-34"], "is_original_packager": [true], "unii": ["W9WZN9A0GM"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0543-2021", "product_description": "Benzoyl Peroxide 10% Acne Medication Wash Net Wt 5 oz (142 g) Distributed By Perrigo Allegan, MI 49010, NDC 45802-318-01", "product_quantity": "31 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA088325"], "brand_name": ["LIDOCAINE HYDROCHLORIDE"], "generic_name": ["LIDOCAINE HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-4275", "0409-4713", "0409-4278", "0409-4279", "0409-4776", "0409-4282", "0409-4277", "0409-4276"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INFILTRATION", "PERINEURAL"], "substance_name": ["LIDOCAINE HYDROCHLORIDE"], "rxcui": ["1010033", "1010671", "1010900", "1737343", "1737562", "1737566", "1737568", "1737636", "1737757", "1737763"], "spl_id": ["d0322a93-069a-453f-89eb-e5d5559ed075"], "spl_set_id": ["3b2dd84e-cee8-4e58-d494-395a65a353a0"], "package_ndc": ["0409-4713-12", "0409-4713-26", "0409-4713-02", "0409-4713-72", "0409-4713-62", "0409-4713-75", "0409-4713-65", "0409-4713-42", "0409-4713-25", "0409-4713-32", "0409-4278-16", "0409-4278-01", "0409-4279-16", "0409-4279-02", "0409-4776-10", "0409-4776-01", "0409-4282-11", "0409-4282-25", "0409-4282-01", "0409-4282-12", "0409-4282-02", "0409-4277-16", "0409-4277-01", "0409-4277-17", "0409-4277-02", "0409-4276-16", "0409-4276-01", "0409-4276-17", "0409-4276-02", "0409-4275-16", "0409-4275-01"], "is_original_packager": [true], "unii": ["V13007Z41A"]}, "product_type": "Drugs", "event_id": "87837", "recalling_firm": "PFIZER, INC", "address_1": "275 N Field Dr Bldg H3-3N", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Puerto Rico, and Guam", "recall_number": "D-0627-2021", "product_description": "1% Lidocaine HCl Injection, USP, 300 mg/30 mL (10 mg/mL), 30 mL Single-dose vial (NDC 0409-4279-16), packaged in 25 vials per tray (NDC 0409-4279-02), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA.", "product_quantity": "139,050 vials", "reason_for_recall": "Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contain 1% Lidocaine HCl Injection, USP and some vials labeled to contain 1% Lidocaine HCl Injection, USP may contain 0.5% Bupivacaine Hydrochloride Injection, USP", "recall_initiation_date": "20210503", "center_classification_date": "20210610", "termination_date": "20230404", "report_date": "20210609", "code_info": "Lot EG8933, Exp. 08/01/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0552-2021", "product_description": "LYRICA (pregabalin) capsules, 200mg 90-count bottle, Rx Only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, MADE IN SINGAPORE", "product_quantity": "49 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "CK1081"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87547", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to MD, CO & TX only", "recall_number": "D-0321-2021", "product_description": "Macula Pellets Homeopathic Medicine, 1 Oz bottles, Rx only, Manufactured for: Natural Ophthalmics Inc. PO Box 1510 Dillon, CO 80435, NDC 58770-190-42", "product_quantity": "1,909 bottles", "reason_for_recall": "An error occurred where the product was manufactured with Potassium Chloride instead of Potassium Phosphate.", "recall_initiation_date": "20210318", "center_classification_date": "20210405", "termination_date": "20210513", "report_date": "20210414", "code_info": "Lot # 27479, exp. date 11/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0587-2021", "product_description": "Restora Omega-3 enhanced Lactobacillus Casei KE-99 30 Capsules 1 A Day Nutritional Supplement NDC 52747-200-30 Marketed by US Pharmaceutical Corporation, P.O. Box 360465, Decatur, GA 30036", "product_quantity": "31 cartons", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0519-2021", "product_description": "VITAMIN D3 50MCG 100 CALC; NDC/UPC 880681170007; OTC; TABLETS", "product_quantity": "427 BOTTLE", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Maumee", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["505G(a)(3)"], "brand_name": ["LITE NFOAMY E2 SANITIZING HANDWASH"], "generic_name": ["BENZALKONIUM CHLORIDE"], "manufacturer_name": ["Spartan Chemical Company, Inc."], "product_ndc": ["64009-333"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["BENZALKONIUM CHLORIDE"], "rxcui": ["1020365", "1493162"], "spl_id": ["4094e03d-6b68-262d-e063-6394a90a3001"], "spl_set_id": ["eb72b3ba-9cdd-40af-8e02-aa4b78ee02cc"], "package_ndc": ["64009-333-95", "64009-333-98"], "is_original_packager": [true], "upc": ["0753727261161", "753727261161"], "unii": ["F5UM2KM3W7"]}, "product_type": "Drugs", "event_id": "87633", "recalling_firm": "Spartan Chemical Co Inc", "address_1": "1110 Spartan Dr", "address_2": "N/A", "postal_code": "43537-1725", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico; Mexico", "recall_number": "D-0362-2021", "product_description": "Lite'n Foamy E2 Sanitizing Handwash (Benzalkonium Chloride, 0.13%), Net Contents: 1 US Gallon/ 3.79 Liters per gallon container, For Institutional and Industrial Use Only, Spartan Chemical Company, Inc., 1110 Spartan Drive, Maumee, OH 43537 USA. UPC 7 53727 26116 1 NDC: 64009-333-95", "product_quantity": "2,152 containers", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20210329", "center_classification_date": "20210430", "termination_date": "20231016", "report_date": "20210421", "code_info": "Lot, expiry: Lot 538882, exp 1/22/2023"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87950", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-0636-2021", "product_description": "Diflorasone Diacetate Ointment USP, 0.05%, packaged in a)15 g (NDC 52565-063-15) and b) 30 g (NDC 52565-063-30) tubes, Rx only, Manufactured by: Teligent Pharma, Inc, Buena, NJ  08310.", "product_quantity": "6,240 tubes", "reason_for_recall": "Presence of Foreign Substance: Foreign particles observed during routine stability testing.", "recall_initiation_date": "20210514", "center_classification_date": "20210623", "termination_date": "20220822", "report_date": "20210630", "code_info": "Lot #: 16264, Exp Date Nov 2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205209"], "brand_name": ["DARIFENACIN"], "generic_name": ["DARIFENACIN"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "product_ndc": ["13668-202", "13668-203"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DARIFENACIN HYDROBROMIDE"], "rxcui": ["485421", "485423"], "spl_id": ["bd53ab8c-821a-4a1b-bcda-4fed3bbd6382"], "spl_set_id": ["e84f1ae3-b9a2-4a15-a299-c75373891cc1"], "package_ndc": ["13668-202-30", "13668-202-90", "13668-202-05", "13668-203-30", "13668-203-05", "13668-203-90"], "is_original_packager": [true], "upc": ["0313668203301", "0313668202304"], "unii": ["CR02EYQ8GV"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0583-2021", "product_description": "Darifenacin Extended-release Tablets 7.5 mg 30 Tablets Rx only Manufactured by: Torrent Pharmaceuticals LTD. Indrad-382 721, India Manufactured for: Torrent Pharma Inc. Basking Ridge, NJ 07920, NDC 13668-202-30", "product_quantity": "52 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "BDZ7G005"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0488-2021", "product_description": "FaBB Vitamin B6 (as Pyridoxine Hydrochloride) 25 mg Folic Acid 2.2 mg Vitamin B12 (as Cyanocobalamin) 1.0 mg Dietary Supplement 100 Tablets Distributed by: H2-Pharma, LLC 2010 Berry Chase Place Montgomery, AL 36117", "product_quantity": "54 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA020725"], "brand_name": ["CREON"], "generic_name": ["PANCRELIPASE"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0032-0045", "0032-1203", "0032-1206", "0032-1212", "0032-1224", "0032-3016", "0032-0046", "0032-0047", "0032-2636", "0032-2637"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PANCRELIPASE AMYLASE", "PANCRELIPASE LIPASE", "PANCRELIPASE PROTEASE"], "rxcui": ["855495", "855499", "855503", "863829", "863836", "863841", "1113042", "1113046", "1373325", "1373327"], "spl_id": ["94463229-9296-4640-854f-41d76386d312"], "spl_set_id": ["073201aa-556d-4a70-918e-84e9616fd88d"], "package_ndc": ["0032-1203-70", "0032-1203-64", "0032-1206-07", "0032-1206-01", "0032-1206-56", "0032-1212-07", "0032-1212-01", "0032-1212-46", "0032-1212-13", "0032-1224-07", "0032-1224-01", "0032-1224-46", "0032-3016-28", "0032-3016-13", "0032-3016-50", "0032-3016-12", "0032-0045-70", "0032-0045-30", "0032-0046-30", "0032-0046-70", "0032-0047-30", "0032-0047-70", "0032-2636-70", "0032-2636-01", "0032-2636-30", "0032-2637-70", "0032-2637-01", "0032-2637-30"], "is_original_packager": [true], "upc": ["0300322637701", "0300320045706", "0300320047700", "0300320046703", "0300323016130", "0300322636704", "0300321224018"], "unii": ["3560D81V50", "YOJ58O116E", "8MYC33932O"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0402-2021", "product_description": "Creon (pancrelipase) Delayed-Release Capsules Dose By Lipase Units Lipase 36,000 USP Units Rx only NDC 0032-3016-13 100 Capsules Marketed by: AbbVie Inc. North Chicago, IL 60064, U.S.A.", "product_quantity": "1669 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "1139494"}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA020832"], "brand_name": ["CHLORAPREP ONE-STEP"], "generic_name": ["CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL"], "manufacturer_name": ["CareFusion 213, LLC"], "product_ndc": ["54365-400"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLORHEXIDINE GLUCONATE", "ISOPROPYL ALCOHOL"], "rxcui": ["858726", "998282"], "spl_id": ["42b89ed3-8625-c3c3-e063-6294a90afa62"], "spl_set_id": ["85416361-90b5-3efa-e053-2a91aa0af431"], "package_ndc": ["54365-400-33"], "is_original_packager": [true], "unii": ["MOR84MUD8E", "ND2M416302"]}, "product_type": "Drugs", "event_id": "87592", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "N/A", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA and to Singapore, Chile, Oman, Columbia, United Arab Emirates, South Africa, Kuwait, Democratic Republic of the Congo, Qatar, Bahrain, Hong Kong, Brazil.", "recall_number": "D-0344-2021", "product_description": "BD ChloraPrep Hi-Lite Orange 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA), Sterile Solution, 0.10 fl. oz. (3 ml) each, 25 Applicators in carton, applicator is sterile if package is intact. CareFusion El Paso, TX 79912, subsidiary of Becton, Dickinson and Co., NDC 54365-400-33 REF 930415", "product_quantity": "1,434,000 cartons", "reason_for_recall": "Non-sterility.Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, growth of Aspergillus penicillioides, a type of fungus, resulted in a breach of the package integrity.", "recall_initiation_date": "20210319", "center_classification_date": "20210426", "termination_date": "20220929", "report_date": "20210505", "code_info": "Lot and Exp Date:  0107872, 4/30/2023;  0108556, 4/30/2023;  0148278, 4/30/2023;  0151978, 5/31/2023;  0155534, 5/31/2023;  0157085, 5/31/2023;  0160618, 5/31/2023;  0167907, 5/31/2023;", "more_code_info": ""}, {"status": "Terminated", "city": "Roswell", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87304", "recalling_firm": "Kimberly-Clark Corporation", "address_1": "1400 Holcomb Bridge Rd", "address_2": "N/A", "postal_code": "30076-2190", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US. Product also distributed in Canada.", "recall_number": "D-0319-2021", "product_description": "Scott\u00bf Moisturizing Foam Hand Sanitizer, 1.2 Liters (40.5 fl oz), Distributed in the U.S. by Kimberly-Clark Global Sales, LLC, Roswell, GA 30076-2199 Distributed in Canada by Kimberly-Clark Inc., Mississauga, Ontario L5B 3Y5 UPC 0 36000 91592 1", "product_quantity": "2,982 cases", "reason_for_recall": "Labeling; Label Mix-up; some bottles containing Foam Skin Cleanser soap are incorrectly labeled as Moisturizing Foam Hand Sanitizer", "recall_initiation_date": "20210201", "center_classification_date": "20210402", "termination_date": "20210921", "report_date": "20210414", "code_info": "Product Code 91590 Lot #WV0280SLA EXP: 2022/09/29"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0478-2021", "product_description": "ADVAIR HFA 45-21MCG 12GM; NDC/UPC 173071520; RX; INHALER MEDICAL INTERNAL - MAY OR MAY NOT BE AEROSOL", "product_quantity": "297 inhalers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "TH4K"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "88079", "recalling_firm": "Bausch Health Companies, Inc.", "address_1": "400 Somerset Corporate Blvd", "address_2": "N/A", "postal_code": "08807-2867", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0638-2021", "product_description": "Mephyton (Phytonadione) 5 mg tablets, 100-count tablets, Rx Only, Manufactured for: Valeant Pharmaceuticals North America, LLC, Bridgewater, NJ, 08807, USA, NDC 0187-1704-05.", "product_quantity": "2,691 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20210608", "center_classification_date": "20210623", "termination_date": "20230216", "report_date": "20210630", "code_info": "Lot #: 19D012P, Exp Date 07/2021; 20D096P, Exp Date 10/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0596-2021", "product_description": "Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide Oral Syrup Net: 1 Pint (473 mL) Bulk Container-Not for Household Use Rx Only NDC 60432-275-16 Distributed By: Wockhardt USA, LLC Parsippany, NJ 07054", "product_quantity": "15 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "UV1092"}]